Epstein Secrets

cility: NYM Date: 07/08/2019 10:41 Provider: PhD/Chief Reg it 76318-054 Unit Team: A&O Comments This writer consulted with Dr. Robert Nagle, Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality including a high profile case with media attention, sex offense c

45 - Current Neuralgia and neuritis, unspecified, M792 - Current Sleep apnea, G4730 - Current PLAN: New Medication Orders: Medication Omega 3 ( Vascepa) 1 GM Capsule Indication: Hyperlipidemia, unspecified New Laboratory Requests: DetaiK Lab Tests-H-Hemoglobin Al C Lab Tests-L-Lipid Profile Add

: Staff recall conducted 3:14 pm: FBI arrives 7:56 pm: FBI departs 9:45 pm: FBI returns 10:30 pm: FBI departs Tuesday, August 13, 2019 8:00 am: Central Office staff arrive 7:30 am: Department Head meeting conducted 8:45 am: Regional Director arrives EFTA00130123 UNITED STATES GOVERNMENT ' MEMORANDUM

emoved and personal items were kept on the top bunk. Amongst these were medications and supplements including Vitamin C 500 mg, Tolnaftate Cream 1%, Vascepa Omega 3, two boxes of Acetaminophen 500 mg which were both sealed closed, Multivitamins, a sealed container of Milk of Magnesia, Methylprednisolone

Sex: M Facility: NYM Date: 07/08/2019 10:41 Provider: PhD/Chief Reg #: 76318-054 Unit Team: A&O Comments This writer consulted with Dr. , Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality including a high profile case with media attention, sex offense c

Current Neuralgia and neuritis, unspecified, M792 - Current Sleep apnea, G4730 - Current PLAN: New Medication Orders: JIM Medication Omega 3 ( Vascepa) 1 GM Capsule Order Date 07/14/2019 17:36 Indication: Hyperlipidemia, unspecified New Laboratory Requests: Details Frequency Lab Tests-H-Hemogl

ication Death Notification for Epstein (#76318-054) @ NYM successfully received on 2019-08-12 @ 14:30:08 (Eastern) Notification sent to R ion and Central Office including the Medical Director and OQM. Submitted by: [8OP527811 Local Date And Time of Pronounced Legal Death: 08/10/2019 07:36 Location: Commun

rd Epstein #73618-054 a 66 year old male with a history of Obstructive Sleep Apnea on CPAP at night, a history of Hypertriglyceridemia treated with Vascepa, no past Mental Health History prior to incarceration and L4-L5 Stenosis. On July 23, 2019, at 2:00 a.m. he was placed on Suicide Watch for 31 hou

: Staff recall conducted 3:14 pm: FBI arrives 7:56 pm: FBI departs 9:45 pm: FBI returns 10:30 pm: FBI departs Tuesday, August 13, 2019 8:00 am: Central Office staff arrive 7:30 am: Department Head meeting conducted 8:45 am: Regional Director arrives EFTA00063568 UNITED STATES GOVERNMENT MEMORANDUM Me

emoved and personal items were kept on the top bunk. Amongst these were medications and supplements including Vitamin C 500 mg, Tolnaftate Cream 1%, Vascepa Omega 3, two boxes of Acetaminophen 500 mg which were both sealed closed, Multivitamins, a sealed container of Milk of Magnesia, Methylprednisolone

or, SER Dr. Jennifer Rogers, Chief Psychologist, FCI Tallahassee Kevin Toney, Correctional Programs Administrator, Correctional Programs Division, Central Office Alan Cohen, Associate Warden, FMC Carswell Joshua Sutton, Captain, FCI Talladega Should you have any questions, please give me a call. EFTA000494

rd Epstein #73618-054 a 66 year old male with a history of Obstructive Sleep Apnea on CPAP at night, a history of Hypertriglyceridemia treated with Vascepa, no past Mental Health History prior to incarceration and L4-L5 Stenosis. On July 23, 2019, at 2:00 a.m. he was placed on Suicide Watch for 31 hou

te: 07/08/2019 10:41 Provider: Miller, Elissa PhD/Chief Reg #: 76318-054 Unit Team: A&O Comments This writer consulted with Dr. Robert Nagle, Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality including a high profile case with media attention, sex offense c

MCC Begin Date: 07/02/2019 Inmate: EPSTEIN, JEFFREY Reg #: 76318-054 End Date: 07/30/2019 Quarter: Z04-206LAD Active Prescriptions Omega 3 (Vascepa) 1 GM Capsule Take two capsules (2 GM) twice daily by mouth with food Rx#: 121885-NYM Doctor: Beaudouin, Robert MD Start: 07/17/19 Exp: 01/13/20

te: 07/08/2019 10:41 Provider: Miller, Elissa PhD/Chief Reg #: 76318-054 Unit Team: A&O Comments This writer consulted with Dr. Robert Nagle, Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality including a high profile case with media attention, sex offense c

G Tab ( 21 count Pack) Take the tablet by mouth as directed Rx#: 121836-NYM Doctor: Beaudouin, Robert MD Start: 07/12/19 Exp: 07/18/19 Omega 3 (Vascepa) 1 GM Capsule Take two capsules (2 GM) twice daily by mouth with food Rx#: 121885-NYM Doctor: Beaudouin, Robert MD Start: 07/17/19 Exp: 01/13/20

te: 07/08/2019 10:41 Provider: Miller, Elissa PhD/Chief Reg #: 76318-054 Unit Team: A&O Comments This writer consulted with Dr. Robert Nagle, Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality including a high profile case with media attention, sex offense c

h plenty of water Milk of Magnesia Susp (OTC) (473ML) 400MG/5ML Exp: 10/28/2019 SIG: shake well take 10ml by mouth twice daily AS NEEDED Omega 3 (Vascepa) 1 GM Capsule Exp: 01/13/2020 SIG: Take two capsules (2 GM) twice daily by mouth with food OTCs: Listing of all known OTCs this inmate is currently

M r ){5): (b)(7;(C) I PhD/Chief **SENSITIVE BUT UNCLASSIFIED** Reg#: 76318-054 Unit Team: A&O This writer consulted wit ........,~~~~,.........Central Office, regarding inmate Epstein. Inmate Epstein has various risk factors for suicidality inclu mg a 19 pro I e case with media attention, sex offense char

h plenty of water Milk of Magnesia Susp (OTC) (473ML) 400MG/5ML Exp: 10/28/2019 SIG: shake well take 10ml by mouth twice daily AS NEEDED Omega 3 (Vascepa} 1 GM Capsule Exp: 01/13/2020 SIG: Take two capsules (2 GM) twice daily by mouth with food OTCs: Listing of all known OTCs this inmate is currently